Cited by 972Cancer-related Molecular PathwaysDNA Repair MechanismsHeat shock proteins research

The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Open access

Shieh, Sheau-Yann, Ahn, Jinwoo, Tamai, Katsuyuki, Taya, Yoichi, Prives, Carol·2000·Genes & Development

Open this paper in CoChat — free account Open PDF

Abstract

Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.14.3.289

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
Background
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citation
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citation
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citation
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474

Flagged first, then by citations

Show all 84 references

6 of the 84 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013

Sorted by citations

Items 701–800 of 964

The interplay between DNA damage response and mitochondrial dysfunction in radiotherapy
Yang, S., Li, Y., Zhang, J., Shen, A., Hu, B., & Yan, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1642100 · Cited by 16
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells
Dingwall, S., Lee, J. B., Guezguez, B., Fiebig‐Comyn, A., McNicol, J. D., Boreham, D. R., Collins, T. J., & Bhatia, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4165 · Cited by 12
In vivo role of checkpoint kinase 2 in signaling telomere dysfunction
Beccaria, M. G., Martínez, P., Flores, J. M., & Blasco, M. A. (2014) · Aging Cell · doi:10.1111/acel.12237 · Cited by 11
Therapeutic strategies for head and neck cancer based on p53 status
Ota, I., Okamoto, N., Yane, K., Takahashi, A., Masui, T., Hosoi, H., & Ohnishi, T. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.474 · Cited by 11
Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway
Hu, Y.-C., Hsieh, B.-S., Cheng, H.-L., Huang, L., Huang, T.-C., Huang, I., & Chang, K. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.008 · Cited by 11
CR229, a novel derivative of β‐carbolin‐1‐one, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation
Kim, M. K., Oh, H. L., Choi, B., Lim, H., Cho, Y.-H., & Lee, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00552.x · Cited by 11
Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53
Yuan, J., Tang, W., Luo, K., Chen, X., Gu, X., Wan, B., & Yu, L. (2006) · Molecular Biology Reports · doi:10.1007/s11033-006-6273-5 · Cited by 11
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice
Carr, M. I., Roderick, J. E., Zhang, H., Woda, B. A., Kelliher, M. A., & Jones, S. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611798114 · Cited by 11
Erythrosine B and quinoline yellow dyes regulate DNA repair gene expression in human HepG2 cells
Chequer, F. M. D., Venâncio, V. P., Almeida, M. R., Aissa, A. F., Bianchi, M. L. P., & Antunes, L. M. G. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717715186 · Cited by 12
Prédisposition héréditaire au cancer du sein (1)
Cohen‐Haguenauer, O. (2019) · médecine/sciences · doi:10.1051/medsci/2019003 · Cited by 12
Microchip-Based Structure Determination of Disease-Relevant p53
Solares, M. J., Jonaid, G. M., Luqiu, W. Y., Liang, Y., Evans, M. C., Dearnaley, W. J., Sheng, Z., & Kelly, D. F. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03599 · Cited by 11
Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry
Nguyen‐Dumont, T., Dowty, J. G., Steen, J. A., Renault, A., Hammet, F., Mahmoodi, M. S., Theys, D., Rewse, A., Tsimiklis, H., Winship, I., et al. (2021) · Cancers · doi:10.3390/cancers13061378 · Cited by 11
Autosomal dominant polycystic kidney disease unlinked to thePKD1 and PKD2loci presenting as familial cerebral aneurysm
McConnell, R. S., RUBINSZTEIN, D. C., FANNIN, T. F., MCKINSTRY, C. S., KELLY, B., BAILEY, I. C., & HUGHES, A. E. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.4.238 · Cited by 11
A novel pathological role of p53 in kidney development revealed by gene-environment interactions
Fan, H., Harrell, J. R., Dipp, S., Saifudeen, Z. R., & El-Dahr, S. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00246.2004 · Cited by 11
CHEK2 gene alterations independently increase the risk of death from breast cancer in Bulgarian patients
Angelova, S. G., Krasteva, M. E., Gospodinova, Z. I., & Georgieva, E. (2012) · Neoplasma · doi:10.4149/neo_2012_079 · Cited by 10
Stress Factors as Possible Regulators of Pluripotent Stem Cell Survival and Differentiation
Darwish, T., Swaidan, N. T., & Emara, M. M. (2023) · Biology · doi:10.3390/biology12081119 · Cited by 10
Non-tumor cells from an MSH2-null individual show altered cell cycle effects post-UVB
Narine, K. A. D., Felton, K. E. A., Parker, A., Tron, V. A., & Andrew, S. E. (2007) · Oncology Reports · doi:10.3892/or.18.6.1403 · Cited by 10
Ethanol-induced DNA repair in neural stem cells is transforming growth factor β1-dependent
Hicks, S. D., & Miller, M. W. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.003 · Cited by 11
Network mechanisms and dysfunction within an integrated computational model of progression through mitosis in the human cell cycle
Terhune, S. S., Jung, Y., Cataldo, K. M., & Dash, R. K. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007733 · Cited by 11
Interaction with Checkpoint Kinase 1 Modulates the Recruitment of Nucleophosmin to Chromatin
Chen, S., Maya‐Mendoza, A., Zeng, K., Tang, C. W., Sims, P. F. G., Loric, J., & Jackson, D. A. (2009) · Journal of Proteome Research · doi:10.1021/pr900396d · Cited by 10
The genetics of familial lymphomas
Siddiqui, R., Onel, K., Facio, F. M., & Offit, K. (2004) · Current Oncology Reports · doi:10.1007/s11912-004-0064-8 · Cited by 10
TOWARD MAINTAINING THE GENOME
Nyberg, K. A., Michelson, R. J., Putnam, C. W., & Weinert, T. A. (2002) · Cited by 10
NOVEL TARGETS IN THE CELL CYCLE AND CELL CYCLE CHECKPOINTS
Pommier, Y. G., Yu, Q., & Kohn, K. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50003-6 · Cited by 11
Correction: Induction of p16 INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
Skalska, L., White, R. E., Parker, G. A., Turro, E., Sinclair, A. J., Paschos, K., & Allday, M. J. (2013) · PLoS Pathogens · doi:10.1371/annotation/2c4b89c1-6d4a-4bf3-9467-9367227d7e74 · Cited by 10
Disordered regions mediate the interaction of p53 and MRE11
Usluer, S., Galhuber, M., Khanna, Y., Bourgeois, B., Spreitzer, E., Michenthaler, H., Prokesch, A., & Madl, T. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119654 · Cited by 9
ATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 9
miR-92b-3p protects retinal tissues against DNA damage and apoptosis by targeting BTG2 in experimental myopia
Liu, J., Bao, B., Li, T., Yang, Z., Du, Y., Zhang, R., Xin, J., Hao, J., Wang, G., Bi, H., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05288-3 · Cited by 9
Gamma radiation alters cell cycle and induces apoptosis in p53 mutant E6.1 Jurkat cells
Ahmadianpour, M. R., Abdolmaleki, P., Mowla, S. J., & Hosseinkhani, S. (2012) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.09.006 · Cited by 9
Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort
Myszka, A., Karpiński, P., Ślężak, R., Czemarmazowicz, H., Stembalska, A., Gil, J., Łaczmańska, I., Bednarczyk, D., Szmida, E., & Sasiadek, M. M. (2010) · Journal of Applied Genetics · doi:10.1007/s13353-010-0013-1 · Cited by 9
DNA Damage Response Pathways and Cancer
Ford, J. M., & Kastan, M. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00011-6 · Cited by 9
Activation of Checkpoint Kinase 2 Is Critical for Herpes Simplex Virus Type 1 Replication in Corneal Epithelium
Alekseev, O., Limonnik, V., Donovan, K., & Azizkhan‐Clifford, J. (2014) · Ophthalmic Research · doi:10.1159/000366228 · Cited by 9
Mitotic Arrest by Tumor Suppressor RASSF1A Is Regulated via CHK1 Phosphorylation
Jiang, L., Rong, R., Sheikh, M. S., & Huang, Y. K. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0482 · Cited by 9
Semisynthetic ‘designer’ p53 sheds light on a phosphorylation–acetylation relay
Margiola, S., Gerecht, K., & Müller, M. M. (2021) · Chemical Science · doi:10.1039/d1sc00396h · Cited by 9
Induction of DNA Repair Genes in Mammalian Cells in Response to Genotoxic Stress
Christmann, M., Fritz, G., & Kaina, B. (2006) · Springer eBooks · doi:10.1007/7050_014 · Cited by 9
Selective depletion of human DNA-methyltransferase DNMT1 proteins by sulfonate-derived methylating agents.
Chuang, L. S.-H., Tan, E. H.-H., Oh, H.-K., & Li, B. F.-L. (2002) · PubMed · Cited by 9
hMTH1 depletion promotes oxidative-stress-induced apoptosis through a Noxa- and caspase-3/7-mediated signaling pathway
Youn, C.-K., Jun, J. Y., Hyun, J. W., Hwang, G., Lee, B. R., Chung, M. H., Chang, I. Y., & You, H. J. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.07.010 · Cited by 9
The infant mouse as a in vivo model for the detection and study of DNA damage–induced changes in the liver
Reynolds, R. P., Witherspoon, S. M., & Fox, T. R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20017 · Cited by 9
The anticancer effects of Aronia berry extract are mediated by Chk1 and p53 in colorectal cancer
Asahi, Y., Xu, C., Okuno, K., Taketomi, A., & Goel, A. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156086 · Cited by 8
Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review)
Lee, J., Wu, C., Duh, T., Chiu, T., Chiu, C., Lee, C.-H., & Chen, J. Y. (2024) · Biomedical Reports · doi:10.3892/br.2024.1870 · Cited by 8
Thymic epithelial cells amplify epigenetic noise to promote immune tolerance
Gamble, N., Caldwell, J. A., McKeever, J. A., Kaiser, C., Bradu, A., Dooley, P. J., Klemm, S. L., Greenleaf, W. J., Hibino, N., Dinner, A. R., et al. (2025) · Nature · doi:10.1038/s41586-025-09424-x · Cited by 8
EAPP modulates the activity of p21 and Chk2
Andorfer, P., Schwarzmayr, L., & Rotheneder, H. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16247 · Cited by 8
Biological Effects of HDAC Inhibitors Vary with Zinc Binding Group: Differential Effects on Zinc Bioavailability, ROS Production, and R175H p53 Mutant Protein Reactivation
Flores, B., Uppalapati, C. K., Pascual, A. S., Vong, A., Baatz, M., Harrison, A. M., Leyva, K. J., & Hull, E. E. (2023) · Biomolecules · doi:10.3390/biom13111588 · Cited by 8
Chromatin structure related to oncogenesis
Matsumoto, S., Horikoshi, N., Takizawa, Y., & Kurumizaka, H. (2023) · Cancer Science · doi:10.1111/cas.15850 · Cited by 8
Signalling DNA Damage
Joaquin, A., & Fernández-Capetillo, Ó. (2012) · InTech eBooks · doi:10.5772/50863 · Cited by 14
A novel regulator (USP10) of p53: Implications for tumor suppression and therapeutic targeting
Reece, K. M., & Figg, W. D. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.8.11690 · Cited by 8
The Life Cycle of P53: A Key Target in Drug Development
Finlan, L. E., & Hupp, T. R. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_7 · Cited by 8
Enhanced Binding Affinity via Destabilization of the Unbound State: A Millisecond Hydrogen–Deuterium Exchange Study of the Interaction between p53 and a Pleckstrin Homology Domain
Zhu, S., Khatun, R., Lento, C., Sheng, Y., & Wilson, D. J. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00193 · Cited by 8
Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress
Sun, T.-P., & Shieh, S.-Y. (2009) · Oncogene · doi:10.1038/onc.2009.58 · Cited by 8
Self-citation
BRCA-1, BRCA-2 and Hereditary Breast Cancer
Bove, B. A., Dunbrack, R. L., & Godwin, A. K. (2002) · CRC Press eBooks · doi:10.1201/b14039-20 · Cited by 8
Tissue-Specific Regulation of Chk1 Expression by p53
Cheung, K.-J., & Li, G. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2398 · Cited by 8
Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients
Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8
A multi-modal proteomics strategy for characterizing posttranslational modifications of tumor suppressor p53 reveals many sites but few modified formsPreprint
DeHart, C. J., Fornelli, L., Anderson, L. C., Fellers, R. T., Lü, D., Hendrickson, C. L., Lahav, G., Gunawardena, J., & Kelleher, N. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/455527 · Cited by 8
The pluripotent-to-totipotent state transition in mESCs activates the intrinsic apoptotic pathway through DUX-induced DNA replication stress
Jia, S., Wen, X., Zhu, M., & Fu, X. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05465-z · Cited by 7
ATM/Chk2 and ATR/Chk1 Pathways Respond to DNA Damage Induced by Movento® 240SC and Envidor® 240SC Keto-Enol Insecticides in the Germarium of Drosophila melanogaster
González-Marín, B., Calderón-Segura, M. E., & Sekelsky, J. J. (2023) · Toxics · doi:10.3390/toxics11090754 · Cited by 7
Bradykinin B2receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis
El-Dahr, S. S., Aboudehen, K., & Dipp, S. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90378.2008 · Cited by 7
ATM: From Phenotype to Functional Genomics — And Back
Shiloh, Y. (2002) · Springer eBooks · doi:10.1007/978-3-662-04667-8_4 · Cited by 7
MDM2/P53 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
Zhu, Y. Y., Wang, H., & Thuraisamy, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816435-8.00015-8 · Cited by 7
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Ingvarsson, S., Sigbjörnsdóttir, B. I., Hafsteinsdottir, S. H., Egilsson, V., & Bergþorsson, J. Þ. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)81460-x · Cited by 7
High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy
de Bruin, L. B., Schuuring, E. M. D., de Bock, G. H., Slagter‐Menkema, L., Mastik, M. F., Noordhuis, M. G., Langendijk, J. A., Kluin, P. M., & van der Laan, B. F. A. M. (2020) · The Laryngoscope · doi:10.1002/lary.28641 · Cited by 7
Tissue-specific regulation of checkpoint kinase 2 expression by p53
Chin, M. Y., & Li, G. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00088-1 · Cited by 7
Generation and Application of Phospho-specific Antibodies for p53 and pRB
Taya, Y., Nakajima, K., Yoshizawa‐Kumagaye, K., & Tamai, K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:17 · Cited by 7
Self-citation
Cisplatin Resistance
Siddik, Z. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_16 · Cited by 7
Overexpression of RFT induces G1–S arrest and apoptosis via p53/p21Waf1 pathway in glioma cell
Kano, H., Arakawa, Y., Takahashi, J. A., Nozaki, K., Kawabata, Y., Takatsuka, K., Kageyama, R., Ueba, T., & Hashimoto, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.120 · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature
Kciuk, M., Wanke, K., Marciniak, B., Kołat, D., Aleksandrowicz, M., Mujwar, S., Ainane, T., & Kontek, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031152 · Cited by 7
Mechanisms of DNA Damage Response in Mammalian Oocytes
Sun, F., Šutovský, P., Patterson, A. L., & Balboula, A. Z. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-55163-5_3 · Cited by 6
Effect and Mechanism of Apple Polyphenols in Regulating Intestinal Flora and Inhibiting the TLR4/NF-κB/TGF-β Signaling Pathway to Alleviate Alcoholic Liver Fibrosis
Meng, X., Ma, Y., Li, K., Ji, M., Lin, L., Xiao, X., Zhao, Y., & Su, G. (2024) · Plant Foods for Human Nutrition · doi:10.1007/s11130-024-01235-1 · Cited by 6
Mechanisms of hepatocarcinogenesis in chronic hepatitis C
Mitchell, J. K., & McGivern, D. R. (2014) · Hepatic Oncology · doi:10.2217/hep.14.7 · Cited by 6
Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma
Martinikova, A. S., Burócziová, M., Stoyanov, M., & Macůrek, L. (2020) · Cells · doi:10.3390/cells9092068 · Cited by 6
JAK2-CHK2 signaling safeguards the integrity of the mitotic spindle assembly checkpoint and genome stability
Chowdhury, M. A. N., Wang, S., Suen, C., Hwang, M., Hsueh, Y.-A., & Shieh, S.-Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05077-0 · Cited by 6
Self-citation
MAB21L1 promotes survival of lens epithelial cells through control of αB-crystallin and ATR/CHK1/p53 pathway
Xiao, Y., Xiang, J., Gao, Q., Bai, Y.-Y., Huang, Z.-X., Hu, X., Wang, L., & Li, D. W. (2022) · Aging · doi:10.18632/aging.204203 · Cited by 6
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications
Pieroni, S., Castelli, M., Piobbico, D., Ferracchiato, S., Scopetti, D., Di-Iacovo, N., Fazia, M. A. D., & Servillo, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214480 · Cited by 6
Phosphorylation Mediated Regulation of Cdc25 Activity, Localization and Stability
Frazer, C., & Young, P. G. (2012) · InTech eBooks · doi:10.5772/48315 · Cited by 7
Zebrafish as Aging Models
Kishi, S. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50029-1 · Cited by 6
Diverse functions of BRCA1 in the DNA damage response
Lee, J., & Chung, J. H. (2001) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399401003131 · Cited by 6
Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability
Baughan, S. L., Darwiche, F., & Tainsky, M. A. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.03.003 · Cited by 5
Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma
Eraky, A. M. (2023) · Cureus · doi:10.7759/cureus.34593 · Cited by 5
Finnish-specific AKT2 gene variant leads to impaired insulin signalling in myotubes
Mäkinen, S., Datta, N., Rangarajan, S., Nguyen, Y. H., Olkkonen, V. M., Latva‐Rasku, A., Nuutila, P., Laakso, M., & Koistinen, H. A. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0285 · Cited by 5
Time varying causal network reconstruction of a mouse cell cycle
Masnadi-Shirazi, M., Maurya, M. R., Pao, G. M., Ke, E., Verma, I. M., & Subramaniam, S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2895-1 · Cited by 5
The interface between the cell cycle and programmed cell death in higher plants: from division unto death
Francis, D. A. (2003) · Advances in botanical research · doi:10.1016/s0065-2296(05)40004-x · Cited by 5
DNA Damage Response Pathways and Cancer
Ford, J. M., & Kastan, M. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50013-0 · Cited by 5
Dual signaling mechanisms of estrogen: Phosphorylation of P53 at Ser15 in aging HMEC in the absence of estrogen receptor
Hass, R., von Wasielewski, R., Fazekas, U., Bartels, H., Jans, E., & Lück, H. (2004) · Signal Transduction · doi:10.1002/sita.200400038 · Cited by 5
Breast Cancer Genetics for Plastic Surgeons
McInerney, N. M., Narod, S. A., Metcalfe, K. A., Semple, J. L., & Brown, M. H. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003577 · Cited by 4
Pancancer Fine‐Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma
Wang, T., Zhao, H., Sun, X., Ding, Y., Zhu, Z., Yu, X., Zhu, R., Wang, D., Li, K., Liu, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202521265 · Cited by 4
Damsel in distress calling on her knights: Illuminating the pioneering role of E3 ubiquitin ligases in guarding the genome integrity
Sahay, O., Barik, G. K., Sharma, T., Pillai, A. D., Rapole, S., & Santra, M. K. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103261 · Cited by 4
Cyclin-dependent kinase 2 (CDK2)
Elmasry, G. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00030-9 · Cited by 4
Cell Cycle Checkpoints and Senescence
Wadhwa, R., Kaul, Z., & Kaul, S. C. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_9 · Cited by 4
Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers
Siddik, Z. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-89445-4_9 · Cited by 4
Molecular Genetics of Breast Cancer
Ingvarsson, S. (2003) · International Journal of Human Genetics · doi:10.31901/24566330.2003/03.02.01 · Cited by 4
Role of ATM in Radiation Signal Transduction
Lavin, M. F., Scott, S. P., Chen, P., Kozlov, S., Gueven, N., & Birrell, G. W. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50667-7 · Cited by 4
Unraveling the mechanisms of glioblastoma’s resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs
Alshammari, Q. A., Alshammari, S. O., Alshammari, A., Alfarhan, M., & Baali, F. H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03564-z · Cited by 3
Genome integrity checkpoints in mammalian oogenesis
Schimenti, J. C. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag118 · Cited by 3
p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
Moll, U. M., & Concin, N. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_6 · Cited by 3
Logical network of genotoxic stress-induced NF-kappaB signal transduction predicts putative target structures for therapeutic intervention strategies
Naumann, M. (2009) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s8211 · Cited by 3
PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer
Tu, R., Zhong, D., Li, P., Li, Y., Chen, Z., Hu, F., Yuan, G., Chen, Z., Yu, S., & Song, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2281659 · Cited by 3
DNA Damage Signaling Downstream of ATM
Bunz, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_2 · Cited by 4
Cell Cycle and DNA Damage Response in Postmitotic Neurons
Kruman, I. I. (2011) · InTech eBooks · doi:10.5772/20859 · Cited by 3
Integration of the DNA Damage Response with Innate Immune Pathways
Gordon, M., & Gasser, S. (2011) · InTech eBooks · doi:10.5772/24735 · Cited by 3
The p53 Network
Levine, A. J., Bargonetti, J., Bond, G. L., Hoh, J. J., Onel, K., Overholtzer, M., Stoffel, A., Teresky, A. K., Walsh, C. A., & Jin, S. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5_1 · Cited by 3
A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect
Sun, Y., Myers, C. J., Dicker, A. P., & Lü, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087492 · Cited by 3

Authors: Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
Affiliations: Seisen University (JP)
ORCID: Shieh, Sheau-Yann
Tamai, Katsuyuki
Prives, Carol
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2000-02-01
Volume: 14
Issue: 3
Pages: 289-300
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.14.3.289
PMC: PMC316358
OpenAlex: W2120921507
Cited by: 972
References: 84
Citations by year: 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Princess Takamatsu Cancer Research Fund
National Institutes of Health (CA58316)
National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
MeSH terms: Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks